Skip to main content

. 1992 Sep;36(9):2066–2067. doi: 10.1128/aac.36.9.2066

Bioavailability of rifampin in experimental murine tuberculosis.

J Dickinson, A Guy, D A Mitchison

PMCID: PMC192441 PMID: 1416902

2066

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Fox W. Drug combinations and the bioavailability of rifampicin. Tubercle. 1990 Dec;71(4):241–245. doi: 10.1016/0041-3879(90)90035-7. [DOI] [PubMed] [Google Scholar]
Grosset J., Truffot-Pernot C., Lacroix C., Ji B. Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice. Antimicrob Agents Chemother. 1992 Mar;36(3):548–551. doi: 10.1128/aac.36.3.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
Lecoeur H. F., Truffot-Pernot C., Grosset J. H. Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide. Am Rev Respir Dis. 1989 Nov;140(5):1189–1193. doi: 10.1164/ajrccm/140.5.1189. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES